KIROMIC BIOPHARMA INC (KRBP)
Institutional ownership reported to the SEC as of Q4 2022, across 9 quarters.
10
Reporting holders
$133.7K
Reported value
1.6%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $99.4K | 549,944 | 0.09% | new | NEW |
| ZEKE CAPITAL ADVISORS, LLC | $19.3K | 107,000 | 0.00% | 9q | HELD |
| UBS Group AG | $7.0K | 38,757 | 0.00% | 5q | +109.4%+$3.6K |
| STATE STREET CORP | $3.1K | 16,976 | 0.00% | 6q | HELD |
| CITADEL ADVISORS LLC | $2.2K | options only | 0.00% | 6q | OPTIONS |
| WealthTrust Axiom LLC | $1.8K | 10,000 | 0.00% | 6q | HELD |
| PNC Financial Services Group, Inc. | $724 | 4,000 | 0.00% | 2q | HELD |
| MORGAN STANLEY | $218 | 1,206 | 0.00% | new | NEW |
| GROUP ONE TRADING, L.P. | $35 | 192 | 0.00% | new | NEW |
| WELLS FARGO & COMPANY/MN | $14 | 77 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $7 | 40,962 | 0.00% | 6q | HELD |
| Virtu Financial LLC | $6 | 31,810 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $1 | 4,675 | 0.00% | 3q | -4.1% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 10 | $133.7K | 728,152 | 4 | 1 | 1 | 1.6% |
| Q3 2022 | 12 | $90.3K | 320,506 | 3 | 3 | 3 | 0.0% |
| Q2 2022 | 16 | $200.0K | 474,993 | 6 | 1 | 2 | 0.0% |
| Q1 2022 | 19 | $1.9M | 2,029,827 | 1 | 5 | 7 | 6.7% |
| Q4 2021 | 18 | $4.6M | 2,516,979 | 1 | 8 | 1 | 17.1% |
| Q3 2021 | 22 | $9.2M | 2,438,733 | 11 | 6 | 4 | 18.5% |
| Q2 2021 | 14 | $11.9M | 2,476,255 | 6 | 4 | 2 | 0.0% |
| Q1 2021 | 9 | $5.1M | 542,840 | 4 | 4 | 1 | 0.0% |
| Q4 2020 | 7 | $919.0K | 108,578 | 7 | 0 | 0 | 0.0% |